Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/03/202411:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KHCKraft Heinz Company
06/03/202411:40AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYLBFRoyal Bank (PK)
06/03/202411:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SNNUFSmith and Nephew Plc (PK)
06/03/202411:40AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JLLJones Lang LaSalle Inc
06/03/202411:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:DNNDenison Mines Corp
06/03/202411:40AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:40AMGlobeNewswire Inc.Signaux Girod : Publication relative aux actions et droits de vote au 31.05.2024LSE:0NASSignaux Girod Sa
06/03/202411:40AMGlobeNewswire Inc.Announcement of the total number of voting rights as at 31 May 2024EU:KBCAKBC Ancora SA
06/03/202411:40AMGlobeNewswire Inc.Signaux Girod : Publication relative aux actions et droits de vote au 31.05.2024EU:ALGIRSignaux Girod
06/03/202411:40AMPR Newswire (US)Sun Life U.S. lands in the top 10 of Milwaukee Journal Sentinel Top Places to WorkTSX:SLFSun Life Financial Inc
06/03/202411:40AMPR Newswire (US)Sun Life U.S. lands in the top 10 of Milwaukee Journal Sentinel Top Places to WorkNYSE:SLFSun Life Financial Inc
06/03/202411:40AMGlobeNewswire Inc.Annonce du nombre total des droits de vote au 31 mai 2024EU:KBCAKBC Ancora SA
06/03/202411:39AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GSRMUGSR II Meteora Acquisition Corporation
06/03/202411:38AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYLBFRoyal Bank (PK)
06/03/202411:38AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:TRUTransUnion
06/03/202411:38AMBusiness WireProofpoint Announces Expansion of Flagship Annual ‘Protect’ Conference to Showcase Latest Innovations in Human-Centric Cybersecurity to Growing Customer Base
06/03/202411:37AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JLLJones Lang LaSalle Inc
06/03/202411:37AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:OMIOwens and Minor Inc
06/03/202411:37AMPR Newswire (US)BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx
06/03/202411:37AMPR Newswire (US)Sentry partners with Falvey Insurance Group to expand into marine cargo
06/03/202411:37AMPR Newswire (US)BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx
06/03/202411:36AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ERIEErie Indemnity Company
06/03/202411:35AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesEU:VLAValneva SE
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesTG:AYJValneva SE
06/03/202411:35AMGlobeNewswire Inc.Programme de rachat d'actions propres - Déclaration des transactions sur actions propres réalisées du 27 mai 2024 au 31 mai 2024LSE:0OA7Assystem Sa
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesEU:VLAValneva SE
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesVLAP
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesLSE:0OB3Valneva Se